II. Prorok J, Oravecz K, Gazdag P, Kui P, Takács H, Polyák A, Levijoki J, Pollesello P, Koskelainen T, Otsomaa L, Nagy N, Farkas inotropy which is desired in heart failure. However the exact electrophysiological mechanism which determines these two outcomes is not clarified because of the lack of selective inhibitors. In this thesis we would like to address these issues by using novel, selective NCX compounds. The main results can be summarized as follows:
1) The novel NCX inhibitor GYKB-6635 effectively suppressed both mode of the NCX current measured by conventional ramp protocol. Our study showed the GYKB-6635 did not influence the kinetics of the L-type Ca 2+ current and major K + -currents therefore it could be considered a promising experimental tool for future NCX research.
2) The selective NCX inhibition is able to cause both positive and negative inotropy by ORM-10962 in the cardiac cells, depending on the experimental condition. When the reverse mode is facilitated Ca 2+ loss, in the case of forward mode enhancement Ca 2+ gain occurs. The major underlying mechanism is the actual Ca 2+ level of the sarcoplasmic reticulum which strongly depends on the function of the NCX.
3) The selective NCX inhibition by ORM-10962 reverts the hypokalaemia induced positive inotropy: the low [K + ] o increases the intracellular Na + level of the cells which shifts the actual reversal potential of the NCX facilitating reverse mode. The selective NCX inhibition may inhibit preferentially the reverse mode of the NCX under this setting which decreases the intracellular Ca 2+ and cell shortening.
INTRODUCTION
Cardiovascular diseases are associated with high mortality rate, which challenges both the current research activity and the healthcare budget. Since the conventional antiarrhythmic drugs used in the treatment of heart failure have serious side effects there is an increasing demand about new drug targets as well as novel selective inhibitors. One of a prosperous new drug target is the Na + /Ca 2+ exchanger which has pivotal role in several arrhythmias [1] , Nevertheless selective inhibitor has not been available so far. However the recently synthesized, selective compounds may provide novel perspectives in the future drug therapy.
Intracellular calcium homeostasis of the heart
The Ca 2+ homeostasis of the cardiac cells is a fine tuned intracellular circulation of the and does not require any external regulation such as β-adrenergic activation [9] .
Neurohormonal system has a main role and multiple effects on the extrinsic regulation. This system modifies the activity of the heart to arrange the body's requirement in varied physiological and pathological conditions. Signaling pathways of cAMP and proteinkinase-A (PKA) and bindings of their metabolites on beta-adrenergic receptors have a main role to modify the regulation of the heart activity. Due to the phosphorilation of Ca 2+ channels, RyR, SERCA 2a , troponin and phospholamban, an increased Ca 2+ influx and reuptake are caused therefore this leads to a faster reuptake and stronger contraction. Other signaling pathways such as activation of protein-kinase-C also have an important role on several ionic currents [10] .
Role and regulation of the sodium-calcium exchanger
Mammalian Na + /Ca 2+ exchangers (NCX) are members of a large Ca 2+ /CA superfamily, whose primary role is to extrude intracellular Ca 2+ . Three isoforms of NCX exist (NCX1, NCX2, NCX3), but NCX1 is the only isoform expressed in the heart. NCX1 is located in the sarcolemma (primarily in the T-tubules), [11, 12] having 10 transmembrane segments and assembled as a dimmer [13] . Between these segments 5 and 6 is a large cytoplasmic loop playing regulatory role. This loop contains two Ca 2+ binding domains, CBD1 and CBD2. When extracellular Ca 2+ is high, Ca 2+ binds to the CBD domains and increases the channel activity via allosteric activation.
The NCX exchanges 3 Na + to 1 Ca 2+ which implies that the operation of the exchanger is electrogenic [14] . The direction of current corresponds to the mode of operation of NCX:
the forward mode operation (Ca 2+ efflux) generates an inward current, while during the reverse mode (Ca 2+ influx) function outward current is developed. The activity of the NCX has a strong dependence on the momentary value of the membrane potential (action potential) and the intracellular as well as extracellular Na + and Ca 2+ ion levels. Under normal condition the intracellular level of Na + , despite the large magnitude of I Na could be considered relatively constant (8-10 mM). In contrast, the intracellular Ca 2+ alternates from beat to beat which dynamically governs the actual driving force of the NCX depending on the momentary membrane potential. When the NCX driving force is more positive than the membrane potential, the forward mode is active, while the driving force is more negative than the action potential the reverse mode is facilitated. It is suggested that under normal condition, the reverse mode is restricted in the very early phase of the action potential, and no longer than 30-50 ms [10] . However the NCX reverse mode is able to contribute to the Ca 2+ influx which may have a regulatory role in the fuzzy space [12] and/or may contribute to the Ca 2+ trigger mechanism from the SR [15] . Under pathophysiological condition, such as heart failure, the contribution of the reverse mode is increased providing considerable extra Ca 2+ influx which may serve as a compensatory mechanism to counterbalance the SR Ca 2+ loss. The forward mode becomes active when the intracellular Ca 2+ starts to increase and competes with the SR for the Ca 2+ extrusion. In rabbit, dog, and human cells the ratio between SERCA and NCX for the Ca 2+ extrusion is approximately 70:30% [2] . It has important significance during heart failure where the NCX upregulation makes the exchanger nearly 50:50% competitor against SERCA which may contribute to the intracellular Ca 2+ loss.
Pharmacology of the sodium-calcium exchanger
The selective inhibition of the NCX is a long-standing challenge for the cardiac electrophysiologist. Although many pharmacological agents can inhibit the NCX, the interpretation of these results is difficult by the concomitant effects on other ion transporters or transporter systems. For instance, amiloride analogues were using to study Ca 2+ homeostasis in cardiac preparations, but results showed that these agents block the voltage gated Ca 2+ channels [1, 16] . Other drugs such as bepridil or amiodarone are also able to inhibit the NCX, but these molecules are non-selective and their effective concentrations often higher than the concentrations where they exert their primary actions [16] .
Benzyloxyphenyl derivate inhibitors like KB-R7943, SEA0400, SN-6 were used successfully in several NCX studies [1] . These compounds inhibit NCX from the external side. KB-R7943
was the first as a prototype in this NCX inhibitor family, which preferentially inhibits the reverse mode operation of NCX [17] . In cardiac cells the reverse mode blocking effect was larger compared with the forward mode (EC 50 = 0.3 µM on reverse vs. 17 µM on forward mode). SEA0400 is a much more potent NCX blocker (EC 50 =111 nM on the reverse vs. 108 nM on the forward mode, [18, 19] , but both of KB-R7943 and SEA0400 was shown to exert substantial nonspecific effects on several ion channels: I Na , I CaL , I K1 and delayed rectifier K + currents. SN-6 was developed from KB-R7943 [20] , but it also more potently inhibits outward than inward NCX current (EC 50 = 1.9 µM vs 2.3 µM) and also significantly suppresses other currents (I Na , I CaL , I Kr , I Ks , I K1 ), causing AP shortening. The exchanger inhibitory protein (XIP) was developed as NCX inhibitor protein, interacting with the Na + regulatory domain of the NCX and suppresses both transport modes [21] . However, the XIP fails to penetrate through the sarcolemma, so it can be used only intracellularly in patch clamp experiments [22] .
Recently, novel promising NCX inhibitors, ORM-10103 and ORM-10962 have been developed. The ORM-10103 inhibited both modes of the NCX, and successfully suppressed in vitro the pharmacologically induced EADs and DADs [23] in dog heart preparations.
Except for a 20% inhibition of the I Kr , the ORM-10103 did not influence the major ionic currents. More recently a novel compound, ORM-10962 was synthesized exerting considerably lower EC 50 levels with promising selectivity and antiarrhythmic profile [24] .
Possible clinical implications of exchanger inhibition: antiarrhythmic and positive inotropic effect
Pharmacological modulation of the NCX has been emerged as one of the most promising novel therapeutic target in the past decade. The possible outcome of the inhibition of NCX is related to the NCX operational modes: the reverse mode gains the Ca 2+ level of the cell which suppression could be beneficial during Ca 2+ overload while the forward mode extrudes Ca 2+ which reduction may increase the Ca 2+ content of the cell and therefore causes positive inotropy [24, 25] . Several diseases which increase the level of intracellular Na + by reduction of the activity of Na + /K + pump function can lead to marked activation of reverse mode NCX function (such as hypokalaemia), which accounts for the concomitant Ca 2+ accumulation and the subsequent abnormal automaticity [26] . It is suggested that selective NCX inhibition by suppressing either the reverse or the forward mode may have antiarrhythmic effect during Na + induced Ca 2+ load. However the antiarrhythmic effect of selective NCX inhibition is controversial in the literature [1] . NCX inhibitors have shown antiarrhythmic effects in hearth rhythm disturbances evoked by ischemia/reperfusion injury in vivo [27] , in Langendorff perfused hearts [28] [29] [30] [31] [32] [33] , and in pharmacologically simulated ischemia/reperfusion models [34] [35] [36] [37] [38] . The SEA0400 decreased the incidence [38] , and reduced the development of EADs [39] , but it failed to suppress the aconitine induced arrhythmias [40] . In Langendorff-perfused rat hearts SEA0400 even enhanced the arrhythmia incidence and duration [41] . The related studies from our laboratory are also contradictory. SEA0400 did not decrease QTc after dofetilide administration, and failed to prevent the development of Torsades de Pointes tachyarrhythmias (TdPs) in Langendorff-perfused rabbit hearts [42, 43] , while in another paper it effectively reduced the amplitudes of EADs, without influencing APD [38] . In contrast, Milberg et al reported considerable APD shortening effect of SEA0400, furthermore, sotalol or veratridine induced TdPs were also suppressed [39, 44] . Recently Jost et al. [23] claimed that ORM-10103, a novel NCX inhibitor with improved selectivity decreased pharmacologically induced DADs and EADs, confirming previous results performed with SEA0400 [38] . where NCX inhibition by SEA0400 failed to influence the magnitude of the Ca 2+ transient in rabbit [43] , guinea pig [45] , and in dog [46] . The earlier studies were made by using SEA0400 having approximately 20% effect on the I Ca [47] however, novel experiments were carried out with the selective inhibitors ORM-10103 and ORM10962, and provided identical results [24, 48] . In contrast, clear inotropic effect was recorded when rats were used as experimental animal [49] . This discrepancy between the results may highlight some specificity of the selective NCX inhibition as a positive inotropic intervention: such as how does it depend on the shape of the action potential, on the [Na + ] i and [Ca 2+ ] i levels, and on the actual balance between NCX working modes.
Aims of the study
Previous results suggest that the selective inhibition of the NCX could be either cause Ca 2+ gain or loss depending on its actual transport balance [24, 25] 
MATERIALS AND METHODS

Ethical consideration
All experiments were conducted in compliance with the Guide for the Care and were adhered to during the study (NC3Rs Reporting Guidelines Working Group, 2010).
Animals
Cardiac ventricular myocytes were obtained from hearts of adult mongrel dogs of both sexes 
Cell preparation
Isolation of canine ventricular myocytes
Segment perfusion method was used to obtain ventricular cells. Segment of the left ventricular wall containing an arterial branch was cannulated and perfused using modified Langendorff apparatus at a pressure of 60 cmH 2 O, with solutions in the following sequence:
(i) isolation solution supplemented with CaCl 2 (1 mM) and sodium-heparin (0. . Further detailed descriptions of the experiments can be found at the Results section.
Isolation of rat ventricular myocytes
Measurement of L-type calcium current
In the experiments where Ca 2+ handling was necessary to be suppressed the L-type calcium current (I CaL ) was recorded in HEPES-buffered Tyrode's solution supplemented with 
Chemicals
With the exception of ORM-10962 (Orion Pharma, Espoo, Finland) all chemicals were purchased from Sigma-Aldrich Fine Chemicals (St. Louis, MO, USA). ORM-10962 was synthesised by the Orion Pharma, Espoo, Finland. The GYKB-6635 was synthesized by the 10962 and GYKB-6635 were dissolved in DMSO to obtain a 10 mM stock solution. These stock solutions were diluted to reach the desired final concentration (DMSO concentration not exceeding 0.1 %) in the bath. The stock solutions were stored at 4 °C. All solutions used were made freshly prior to the experiment.
Data analysis and statistics
All data are expressed as means ± SEM. Statistical analysis was performed with Student's ttest for paired data. The results were considered statistically significant when the p value was < 0.05. 
RESULTS
Investigation of the NCX inhibition under normal experimental circumstances
pump currents). (B) The current trace after superfusion with 1 µM GYKB-6635. (C) The current trace at the end of the measurements after the application of 10 mM NiCl 2 . On the right, the control NCX current is shown, which is obtained by subtracting trace (C) from trace (B). The NCX current in the presence of 1 µM GYKB-6635 is obtained by subtracting trace (B) from trace (C). Note the difference in the intensity-time calibration in the left and right panels.
The NCX current was measured by using the conventional "ramp" protocol which was described in detail earlier [23] . After control measurements 1 µM GYKB-6635 was applied and finally, the total NCX current was calculated as Ni 2+ sensitive current after application of 10 mM NiCl 2 (Figure 3) . Ramp pulse was applied from a holding potential of -40 mV to 60 mV (1 s duration) and repolarized to -140 mV (2 sec duration). 1 µM GYKB-6635 reduced by 57% the reverse NCX current (from 52.5 ± 18.5 pA in controls to 22.4 ± 11.9 pA after drug administration, n = 4, p < 0.05), while the forward current was reduced by 58% (from -52.7 ± 21 pA in controls to -21.8 ± 12.3 pA after drug administration, n = 4, p < 0.05). 
Inotropic effects of NCX inhibition under normal condition
Inotropic effect of selective NCX inhibition was investigated on cell shortening and Ca 17.32±2.84%, n=6 respectively, p<0.05). These results were practically identical with previous data from our laboratory with ORM-1096, 10103 and SEA-0400 [24, 46] . 
Figure 4.: Evaluation of positive inotropy of 1 µM ORM-10962 on isolated canine ventricular cells under normal conditions. Panels A and B show superimposed representative traces of Ca 2+ transients (A) and CS (B) under control conditions (filled symbols) and after exposure to 1 µM ORM-10962 (open symbols). The cells were paced using field stimulation at 1 Hz. Average results obtained from 6 myocytes are presented in panel C. Columns and bars represent mean ± SEM values, asterisks denote significant changes from control.
Effects of NCX inhibition on SR
ORM-10962 inhibits the reverse NCX mediated positive inotropy
To investigate further the above mentioned observations, transmembrane currents were recorded using the whole cell patch clamp technique parallel with cell shortening.
At these experiments cells were stimulated at 1 Hz with pulses clamped to +30 mV from the holding potential of -70mV. Positive stimulatory potential was used and the Na + content of the external solution was reduced to 70 mM in order to facilitate Ca 2+ influx via reverse mode NCX activity. Representative traces of membrane currents recorded under these conditions are shown in Figure 6A . After application of ORM-10962 outward current measured at the end of the +30 mV pulse. Outward current is significantly decreased (from 150±29 to 82±18 pA, p<0.05, n=8), demonstrating an inhibition of the outward NCX current generated by the reverse mode NCX (Figure 6C ). This marked reduction in outward NCX current was accompanied by a considerable reduction in CS (from 7.7±1.3 to 4.9±1.2 %, p<0.05, n=7), indicating the elimination of positive inotropy mediated by the previously activated reverse mode NCX (Figure 6 B-D) . by a presence of 200 nM forskolin, were applied to reduce reverse and enhance forward mode NCX activity. Figure 7A shows representative traces of I Ca and NCX tail current recorded before and after application of 1 µM ORM-10962 under these conditions. Important to note that after administration of 1 µM ORM-10962 we found considerable reduction in I Ca amplitude shown in Figure 7C (from -948±124 to -613±91 pA, p<0.05, n=10), while the concomitant suppression of inward NCX tail current is an appropriate indicator of forward mode NCX inhibition ( Figure 7D ). Important to note that, in contrast to other studies where non selective NCX inhibitors were used, any negative inotropic effect with NCX compound was not observed in these experiments. In fact, the reduced I Ca was accompanied by a strong increase in CS (from 4.7±1.2 to 7.6±1.4 %, p<0.05, n=10) as presented in Figure 7B -E.
Figure 6.: Effects of 1 µM ORM-10962 on outward NCX current (A, C) and CS (B, D) in the presence of low (70 mM) [Na + ] o . Cells were stimulated at 1 Hz under voltage clamp conditions using voltage steps to +30 mV for 100 ms arising from the holding potential of -70 mV. Superimposed recordings of membrane currents (A) and CS (B), obtained in the presence
These data may indicate the observed decay in peak I Ca is presumably not a consequence of a direct inhibition, but could be a result of the regulation of increased SR Ca 2+ release via its Ca 2+ dependent inactivation [53] . 
Elevated driving force of the forward NCX partially maintains the Ca 2+ efflux after NCX inhibition
The positive inotropic effect of the forward mode NCX inhibition may mean that the [Ca 2+ ] i is elevated, which at the same time provides increased driving force for the forward NCX. In this case the increased driving force may partially balance the reduced NCX capacity after ORM application, which may be manifested as a decrease of the apparent inhibition of inward NCX current, with a possible consequence of limited Ca 2+ accumulation.
This point was examined further with ORM-10962, taking advantage of the fact that there are two ways to measure the inward NCX current that corresponds to the forward mode activity of NCX. Firstly, when NCX removes Ca 2+ from the cell after maximal SR Ca 2+ release during the caffeine superfusion an integral of the generated current is an accepted method for estimation of the SR content, furthermore under this setting the forward NCX activity could be measured by analysis of the peak inward current. 
Selective NCX inhibition reverted the hypokalaemia induced positive inotropy
In order to investigate the effect of NCX inhibition on hypokalaemia induced alteration of cell shortening, a 2.7 mM KCl-contained Tyrode's solution was applied after normal condition at 1 Hz pacing frequency. Under this setting we found significant increase of cell shortening (2.3±1% → 12.3±14%, n=22, p<0.05; Figure 10A ). The subsequently used ORM-10962 reverted the hypokalaemia induced increase in cell shortenings (12.3±14% → 6.12±11%, n=22 respectively, p<0.05; Figure 10B-C) . The extra-beats, contraction waves were also counted during the experiments which were completely absent under normal condition. Under hypokalaemic settings significant number of extra contractions appeared (13.8±2 extras/ 8 minutes; n=22, p<0.05) (Figure 10A) . Similarly to the results of cell shortening the selective NCX inhibition decreased the number of extra beats (7.5±1.8 extra/8 min; n=22, p<0.05; Figure 11A ). In the presence of hypokalaemic solution the cells often exerted paroxysmal "fibrillation" episodes meaning an irregular, high frequency fluttering instead of regular contraction which were termed as 'contraction waves' in this study. Since these waves showed transient nature, we calculated the cumulative duration of the episodes during and experiment and compared these between control and ORM-10962 treated conditions. Under normal settings no contraction waves were detected however in hypokalaemic condition they were present for a period (15.3±4 sec/8 min, n=22, p<0.05, Figure 11B ). In the presence of ORM-10962 the duration of contraction waves were significantly reduced (8.36±2 sec/8 min; n=22, p<0.05; Figure 11B ). 
DISCUSSION
In the present study various effects of novel NCX inhibitors (GYKB-6635 and ORM-10962) were assessed. Emphasis was laid on the following:
(1) Novel NCX inhibitor GYKB-6635 effectively inhibits both mode of the NCX current.
(2) ORM-10962 has no direct blocking effect on L-type Ca 2+ channels in the lack of SR Ca 2+ release but strongly suppresses I Ca under conditions of normal Ca 2+ cycling. 
Effects of GYKB-6635 on the NCX current
The GYKB-6635 effectively inhibited the NCX current in the micromolar range (Fig.3) without any effect on the I Ca or on the major K + -currents (I Kr , I Ks , I K1 ) [54] . This study [54] further showed that GYKB-6635 was effective against DAD-related arrhythmias on guineapig Langendorff-perfused hearts. The improved effectiveness and selectivity of GYKB-6635 obviously highlights from the previous compounds: KB-R7943, SEA0400, and ORM-10103 all have inhibitory effects on I CaL or I Kr which makes the data interpretation difficult [23, 47] .
In contrast, GYKB-6635 could be a novel potential experimental as well as therapeutical tool to investigate the NCX function under physiological or in pathological condition.
Effects of ORM-10962 on I Ca
Our main finding is that ORM-10962 has no direct suppressive effect on L- 
Marginal positive inotropy under baseline conditions
Previous study from our laboratory demonstrated that application of 1 µM ORM-10962 has approximately 90% inhibitory effect of NCX [24] , measured by conventional ramp protocol. 
Inotropic effect of NCX inhibition depends on the relative contribution of reverse NCX activity
A significant negative inotropic action of NCX blockade was described in our previous study, when reverse mode was facilitated by low NaCl containing Tyrode solution [24] . According to these previous results in this study we report that application of ORM-10962 reduced the SR Ca 2+ content following an earlier enhancement of the reverse mode of NCX activity ( Fig.   5A and C) 
Possibility of an asymmetrical NCX blockade
Even though some evidences demonstrating that mode selective NCX inhibition may occur under certain experimental conditions [58] , theoretical considerations do not support the possibility of transport mode dependent inhibition [59] .
Previous papers demonstrated that KB-R7943 and SEA0400 preferentially block the reverse mode NCX [28, 47] . In our previous studies, ORM-10103 or ORM-10962 exerted balanced inhibitory effect between reverse and forward mode [23, 24] , therefore we assume that the possibility of asymmetrical inhibition of the reverse and forward mode as a basis for the limited positive inotropic effects can be ruled out in our experiments.
The forward mode NCX blockade may be alleviated by another potential mechanism and thus the positive inotropic effect is the possible modulatory effect of Ca 2+ on the NCX inhibition.
Such a phenomenon has been implicated in the case of KB-R7943 [60] . When SEA0400 was applied to block NCX in a previous study [46] , some evidence was found which supporting our theory. 
Asymmetrical consequences of NCX inhibition in
Preserved inducibility of forward mode NCX by elevated [Ca
The extent of forward mode NCX suppression can be estimated from inward NCX current traces monitored in the absence and presence of ORM-10962. The rapid application of caffeine deliberates the total amount of SR Ca 2+ , which is subsequently extruded from the cytoplasm by forward mode NCX activity. The integral of the developed inward current is used to estimate the SR Ca 2+ content and the magnitude of forward NCX. After analysis of our experiments it was clear that ORM-10962 is unable to block forward mode NCX completely (Fig. 9A) , and the degree of inhibition calculated from peak, caffeine-induced NCX current traces reached only approx. 30 % -much less than the 80 % blockade expected from the experiments in Ca 2+ buffered cells using similar drug concentrations [23, 24] i level could be developed after NCX inhibition decreasing the apparent degree of inhibition. These results were consequent to our previous findings with SEA-0400 [46] .
NCX inhibition reverts the incidence of arrhythmias and Ca 2+ overload induced cell shortening in hypokalaemia
The increase of reverse NCX mediated Ca 2+ influx by elevation of intracellular Na + level not only promotes the outward NCX ratio during a Ca 2+ handling cycle, but also augments the intracellular Ca 2+ levels resulting in an increased driving force for forward NCX. Our previous results in this study may suggest that in this condition the inward NCX inhibition was attenuated and the effect of reverse NCX blockade will primarily prevail under this circumstance and net Ca 2+ loss is expected. As was hypothesized, in the presence of hypokalaemic solution the Ca 2+ transient was increased presumably after suppression of the Na + /K + pump and consequential Na + i gain which activates Ca 2+ influx through reverse NCX on rat isolated myocytes. This improved Ca 2+ level was decreased after NCX inhibition which could be attributable to the outward exchanger inhibition (Fig. 10) . These results may further support the hypothesis of asymmetrical functional consequences of NCX blockade. As was expected, the adverse effects of elevated intracellular Ca 2+ such as Ca 2+ waves or extra beats were also suppressed (Fig. 11) . It is important to mention here that a substantial species-dependent effect was discovered between rat and dog myocytes regarding NCX inhibition mediated positive inotropy: in our previous studies on rat [43, 49] we found marked increase in Ca 2+ transient and cell shortening/contraction after NCX inhibition, and we failed to reproduce this effect on dog [46] and rabbit [43] These experiments may indicate that when the NCX balance is shifted toward facilitated reverse mode function, the NCX inhibition resulted in uniformly a decrease of the Ca 2+ level, suggesting asymmetrical, reverse NCX-dominant inhibition. However under normal condition, positive inotropic effect was described only in rats [49] and marginal effect was observed in the case of guinea-pig [45] , rabbit [43] , and dogs [46] . These animals have considerable difference in baseline heart rate, in the action potential shape and in the underlying ionic currents which may contribute to this discrepancy. However, regarding the function of the forward NCX it is important to note that "functional capacity" of NCX may be increasing from rat to dog, providing an important reserve for Ca 2+ extrusion. The underlying mechanism of this phenomenon is not clear, it could be related to the autoregulatory mechanism, and/or the persevered inducibility of the NCX in the presence of high Ca 2+ i .
Therapeutic implications: NCX inhibition as a possible positive inotropic intervention
This study suggests that in intact myocytes the functional consequence of NCX inhibition by ORM-10962 is an asymmetrical blockade showing a dominant effect on reverse mode NCX activity. When Ca 2+ influx via reverse mode NCX significantly contributes to Ca 2+ balance the NCX inhibition will be substantial and a net negative inotropic effect is a result of decreased cellular Ca 2+ content.
The positive inotropy due to forward mode NCX inhibition may become apparent during conditions when reverse mode NCX is suppressed and Ca 2+ cycling is stimulated independently from the Ca 2+ influx through reverse mode NCX. In heart failure the NCX reverse activity is increased [66, 67] and the NCX inhibition by ORM-10962 may block primarily the reverse mode NCX. But reverse mode is a rescue mechanism to maintain the cellular Ca 2+ load [66, 67] . This is not necessarily balanced by the decreased Ca 2+ loss, since this latter appears to be a less pronounced consequence of NCX inhibition. Thus the possibility of improving cardiac inotropy by pharmacological NCX inhibition requires further detailed studies in myocytes obtained from failing hearts.
